ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM PO

Test System, Antineutrophil Cytoplasmic Antibodies (anca)

PHADIA US INC.

The following data is part of a premarket notification filed by Phadia Us Inc. with the FDA for Elia Pr3s Immunoassay, Elia Mpos Immunoassay, Elia Gbm Immunoassay, Elia Anca/gbm Positive Control 100, Elia Anca/gbm Po.

Pre-market Notification Details

Device IDK140225
510k NumberK140225
Device Name:ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM PO
ClassificationTest System, Antineutrophil Cytoplasmic Antibodies (anca)
Applicant PHADIA US INC. MUNZINGER STRASSE 7 Freiburg Im Breisgau,  DE 79111
ContactMartin Mann
CorrespondentMartin Mann
PHADIA US INC. MUNZINGER STRASSE 7 Freiburg Im Breisgau,  DE 79111
Product CodeMOB  
Subsequent Product CodeJJY
Subsequent Product CodeMVJ
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-01-29
Decision Date2014-10-27
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
07333066010823 K140225 000
07333066010816 K140225 000
07333066010670 K140225 000
07333066013886 K140225 000
07333066013831 K140225 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.